Gereic Dry Powder Inhaler

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)NCT06274801Gossamer Bio USA, Inc.Phase 3Recruiting2026-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.